Abstract
Molluscan defense mechanisms are regulated to innate immunity, which is largely dependent on cellular components such as hemocytes possessing phagocytic and bactericidal activities. Among immune responses, apoptosis is an indispensable process because it enables the adequate clearance of damaged, senescent and infected cells without inflammation. Available information related to the molecular mechanisms of apoptosis has been accumulated for many molluscan species during the last decade. Almost all molluscan species live in an environment that changes incessantly according to microorganisms, industrial pollutants, temperature, and salinity. Such environmental factors might directly or indirectly induce apoptosis in molluscan cells. One type of apoptotic agent, reactive oxygen intermediates (ROIs), which are produced by a stress signal or phagocytosis, triggers apoptotic cell death in molluscan hemocytes. Dysfunction of ROI-mediated hemocytic apoptosis putatively causes disease morbidity and/or mortality when molluscan organisms are infected by pathogens. Furthermore, integrins have attracted attention for their unique functions because integrins regulate the phagocytic ability of molluscan hemocytes and induce hemocytic apoptosis. That process might be the result of ROI-generation. In this review, we summarize the roles and molecular mechanisms of apoptosis related to immunological functions of molluscan hemocytes.
Keywords: Apoptosis, molluscs, hemocyte, immunity, integrin, nitric oxide, reactive oxygen intermediates, phagocytosis
Current Pharmaceutical Design
Title: Mechanisms and Immunological Roles of Apoptosis in Molluscs
Volume: 14 Issue: 2
Author(s): Kazutaka Terahara and Keisuke G. Takahashi
Affiliation:
Keywords: Apoptosis, molluscs, hemocyte, immunity, integrin, nitric oxide, reactive oxygen intermediates, phagocytosis
Abstract: Molluscan defense mechanisms are regulated to innate immunity, which is largely dependent on cellular components such as hemocytes possessing phagocytic and bactericidal activities. Among immune responses, apoptosis is an indispensable process because it enables the adequate clearance of damaged, senescent and infected cells without inflammation. Available information related to the molecular mechanisms of apoptosis has been accumulated for many molluscan species during the last decade. Almost all molluscan species live in an environment that changes incessantly according to microorganisms, industrial pollutants, temperature, and salinity. Such environmental factors might directly or indirectly induce apoptosis in molluscan cells. One type of apoptotic agent, reactive oxygen intermediates (ROIs), which are produced by a stress signal or phagocytosis, triggers apoptotic cell death in molluscan hemocytes. Dysfunction of ROI-mediated hemocytic apoptosis putatively causes disease morbidity and/or mortality when molluscan organisms are infected by pathogens. Furthermore, integrins have attracted attention for their unique functions because integrins regulate the phagocytic ability of molluscan hemocytes and induce hemocytic apoptosis. That process might be the result of ROI-generation. In this review, we summarize the roles and molecular mechanisms of apoptosis related to immunological functions of molluscan hemocytes.
Export Options
About this article
Cite this article as:
Terahara Kazutaka and Takahashi G. Keisuke, Mechanisms and Immunological Roles of Apoptosis in Molluscs, Current Pharmaceutical Design 2008; 14 (2) . https://dx.doi.org/10.2174/138161208783378725
DOI https://dx.doi.org/10.2174/138161208783378725 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry GSK-3 Inhibitors: Discoveries and Developments
Current Medicinal Chemistry Epigenetics of Virus-Induced Tumors: Perspectives for Therapeutic Targeting
Current Pharmaceutical Design 3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells : in vitro and in vivo Findings
Anti-Cancer Agents in Medicinal Chemistry Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach
Current Neuropharmacology Melamine Derivatives - A Review on Synthesis and Application
Current Organic Synthesis Novel Agents in the Management of Lung Cancer
Current Medicinal Chemistry Perspectives in Medicinal Chemistry: Metalloprotein Inhibitors: What Have We Made and What is the Next Step?
Current Topics in Medicinal Chemistry Chronic Myeloid Leukemia: Existing Therapeutic Options and Strategies to Overcome Drug Resistance
Mini-Reviews in Medicinal Chemistry Nano-Based Therapy for Treatment of Skin Cancer
Recent Patents on Anti-Infective Drug Discovery NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation
Current Immunology Reviews (Discontinued) Targeting Hsp90 in Non-Cancerous Maladies
Current Topics in Medicinal Chemistry Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)
Current Cancer Drug Targets Integrase Strand Transfer Inhibitors and the Emergence of Immune Reconstitution Inflammatory Syndrome (IRIS)
Current HIV Research Safer Vectors for Gene Therapy of Primary Immunodeficiencies
Current Gene Therapy Na+-H+ Exchanger, pH Regulation and Cancer
Recent Patents on Anti-Cancer Drug Discovery Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
Current Molecular Medicine Natural Killer Cells Preferentially Target Cancer Stem Cells; Role of Monocytes in Protection Against NK Cell Mediated Lysis of Cancer Stem Cells
Current Drug Delivery Challenges in the Design of Clinically Useful Brain-targeted Drug Nanocarriers
Current Medicinal Chemistry Xeno-Cannibalism as an Exacerbation of Self-Cannibalism: A Possible Fruitful Survival Strategy for Cancer Cells
Current Pharmaceutical Design